Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipralex in Depressive Symptoms and Chronic Back Pain
NCT00227292Phase 4Withdrawn
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Nov 2007
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in low back pain (LBP) and major depressive disorder (MDD), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Hamilton Depression Rating Scale at 4 weeks. Planned start Nov 2007; status: withdrawn.
02
Drugs
escitalopram
03
Conditions
low back pain (LBP)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00227292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227292.